ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

19.90
Delayed Data
As of Apr 20
 +0.24 / +1.22%
Today’s Change
15.74
Today|||52-Week Range
41.20
-33.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-92.5M-164.4M-271.4M-289.4M
 
 
 
 
 
Depreciation206.0K647.0K1.8M2.7M
 
 
 
 
 
Total Other Cash Flow16.5M37.9M54.8M75.2M
 
 
 
 
 
Funds From Operations-75.7M-125.9M-214.8M-211.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-9.3M-4.5M-6.4M6.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-66.4M-121.4M-208.4M-217.8M
 
 
 
 
 
 
InvestingIncrease In Investments-335.4M-269.9M-683.4M-478.8M
 
 
 
 
 
Decrease In Investments248.3M419.2M430.9M572.1M
 
 
 
 
 
Capital Expenditures-180.0K-2.1M-1.5M-812.0K
 
 
 
 
 
Net Cash Flow Investing-87.3M147.2M-261.9M92.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale203.9M14.5M518.9M31.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.00247.0K14.9M0.00
 
 
 
Other Uses - Financing0.00292.0K0.000.00
 
 
Net Cash Flow - Financing203.9M14.5M533.8M31.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash3.0K7.0K2.0K-6.0K
 
 
 
 
 
 
Net Change In Cash50.1M40.3M63.5M-94.1M